• Latest News
• Upcoming Events
• Publications

Press Release

7 November 2007

Disclosure of Significant Shareholdings

Osmetech PLC (“Osmetech” or “the Company”) announces that on 6 November 2007 it was notified that Efficacy Capital Ltd has increased its shareholding in Osmetech to 27,800,000 Ordinary 0.1p shares.

This represents 13.69% of the Company’s issued share capital of 203,014,972 Ordinary shares.

The shareholding is held in two entities:

Efficacy Biotech Master Fund which holds 24.860,000 shares representing 12.25% of Osmetech’s issued share capital.

FMG Special Opportunity Fund which holds 2,940,000 shares representing 1.45% of Osmetech’s issued share capital.

For further information: